Trivelpiece Takes Top AAAS Post

CHICAGO—Alvin W. Trivelpiece will take office April 1 as executive officer of the American Association for the Advancement of Science, the AAAS announced February 15 at its annual meeting here. He succeeds Wffliam D. Carey, who is retiring after 12 years at the head of the nation's oldest and largest genera! science membership organization. The appointment was reported first in the February 9 issue of THE SCIENTIST. Triveipiece, 56, a nuclear physicist with experience in industry, academia a

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Triveipiece, 56, a nuclear physicist with experience in industry, academia and government, has directed energy research at the Department of Energy since 1981. Previously he served on the faculty at the University of California at Berkeley and the University of Maryland and was vice president at Maxwell Labs in San Diego and at Science Applications Inc. in La Jolla, Calif.

The AAAS meeting drew approximately 3,500 participants, officials said, which is several hundred more than in recent years but still less than half the attendance common in the 1960s.

A three-day symposium on "Frontiers of Neuroscience" held in conjunction with the annual meeting drew more than 400 people, according to its organizer, Daniel L. Alkon of NIH. "I think AAAS is overjoyed at the success of the experiment," Alkon said.

Organizers of the annual meeting had hoped that the symposium would lure biologists and other professionals in the life sciences ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies